Literature DB >> 10511650

Pitfalls in Doppler evaluation of diastolic function: insights from 3-dimensional magnetic resonance imaging.

A Fyrenius1, L Wigström, A F Bolger, T Ebbers, K P Ohman, M Karlsson, B Wranne, J Engvall.   

Abstract

Ultrasound-Doppler assessment of diastolic function is subject to velocity errors caused by angle sensitivity and a fixed location of the sample volume. We used 3-dimensional phase contrast magnetic resonance imaging (MRI) to evaluate these errors in 10 patients with hypertension and in 10 healthy volunteers. The single (Doppler) and triple (MRI) component velocity was measured at early (E) and late (A) inflow along Doppler-like sample lines or 3-dimensional particle traces generated from the MRI data. Doppler measurements underestimated MRI velocities by 9.4% +/- 8.6%; the effect on the E/A ratio was larger and more variable. Measuring early and late diastolic inflows from a single line demonstrated the error caused by their 3-dimensional spatial offset. Both errors were minimized by calculating the E/A ratio from maximal E and A values without constraint to a single line. Alignment and spatial offset are important sources of error in Doppler diastolic parameters. Improved accuracy may be achieved with the use of maximal E and A velocities from wherever they occur in the left ventricle.

Entities:  

Mesh:

Year:  1999        PMID: 10511650     DOI: 10.1016/s0894-7317(99)70186-0

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  15 in total

1.  Three dimensional flow in the human left atrium.

Authors:  A Fyrenius; L Wigström; T Ebbers; M Karlsson; J Engvall; A F Bolger
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  High temporal resolution phase contrast MRI with multiecho acquisitions.

Authors:  Richard B Thompson; Elliot R McVeigh
Journal:  Magn Reson Med       Date:  2002-03       Impact factor: 4.668

Review 3.  Evaluation of nonischemic cardiomyopathies using cardiovascular magnetic resonance.

Authors:  Rory O'Hanlon; Sanjay K Prasad; Dudley J Pennell
Journal:  J Nucl Cardiol       Date:  2008 May-Jun       Impact factor: 5.952

4.  Assessment of left ventricular diastolic function by MR: why, how and when.

Authors:  Ricardo Duarte; Gabriel Fernandez
Journal:  Insights Imaging       Date:  2010-06-15

5.  Measurement of cardiac valve and aortic blood flow velocities in stroke patients: a comparison of 4D flow MRI and echocardiography.

Authors:  Thomas Wehrum; Felix Guenther; Alexander Fuchs; Florian Schuchardt; Anja Hennemuth; Andreas Harloff
Journal:  Int J Cardiovasc Imaging       Date:  2018-01-11       Impact factor: 2.357

Review 6.  Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance.

Authors:  Michael Markl; Philip J Kilner; Tino Ebbers
Journal:  J Cardiovasc Magn Reson       Date:  2011-01-14       Impact factor: 5.364

Review 7.  Fluid dynamics of ventricular filling in heart failure: overlooked problems of RV/LV chamber dilatation.

Authors:  Ares Pasipoularides
Journal:  Hellenic J Cardiol       Date:  2015 Jan-Feb

8.  Mitral valve regurgitation: accurate blood flow quantification with MRI.

Authors:  J J M Westenberg; J Doornbos; J J Bax; M G Danilouchkine; R J van der Geest; G Labadie; H J Lamb; M I M Versteegh; A de Roos; R A E Dion; J H C Reiber
Journal:  Neth Heart J       Date:  2004-09       Impact factor: 2.380

9.  Streamline-based three-dimensional peak-velocity tracing of transvalvular flow using four-dimensional flow cardiac magnetic resonance imaging for left ventricular diastolic assessment in aortic regurgitation: a case report.

Authors:  Paul Njoku; James Wardley; Pankaj Garg
Journal:  J Med Case Rep       Date:  2022-05-16

10.  Cardiovascular magnetic resonance imaging assessment of diastolic dysfunction in a population without heart disease: a gender-based study.

Authors:  Bruno Graça; Maria João Ferreira; Paulo Donato; Miguel Castelo-Branco; Filipe Caseiro-Alves
Journal:  Eur Radiol       Date:  2013-08-03       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.